Aethlon Medical surges after trial for potential monkeypox therapy

Aethlon Medical

10/08/2022 11:51

** Shares of Aethlon Medical Inc  AEMD.O  rise ~14% to $1.49
in premarket trading
    ** Says starting a new test tube experiment to confirm that
its Hemopurifier therapy, a type of blood filtration system,
effectively captures the current strain of monkeypox virus
 urn:newsml:reuters.com:*:nPn1B5kVKa
    ** AEMD says it has confirmed with the FDA the process to
provide Hemopurifier to physicians for single patient emergency
use
    ** Plans to submit a pre-emergency use authorization package
to the FDA for the therapy 
    ** Up to Tuesday's close, stock down 29.6% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))